Zobrazeno 1 - 10
of 1 873
pro vyhledávání: '"Uldrick TS"'
Autor:
Shaik F; Department of Dermatology, University of Kwa-Zulu Natal, Durban 4001, South Africa.; SAMRC Clinician Researcher Development Scholarship PhD Programme, Tygerberg, Cape Town 7505, South Africa., Uldrick TS; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Mazinu M; Biostatistics Research Unit, South African Medical Research Council, Tygerberg, Cape Town 7505, South Africa., Gwebushe N; Biostatistics Research Unit, South African Medical Research Council, Tygerberg, Cape Town 7505, South Africa., Mosam A; Department of Dermatology, University of Kwa-Zulu Natal, Durban 4001, South Africa.; Inkosi Albert Luthuli Central Hospital, Cato Manor, Durban 4091, South Africa.
Publikováno v:
Tropical medicine and infectious disease [Trop Med Infect Dis] 2024 Oct 17; Vol. 9 (10). Date of Electronic Publication: 2024 Oct 17.
Autor:
Lurain K; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Ekwede I; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Eulo V; University of Alabama at Birmingham, Birmingham, AL., Goyal G; University of Alabama at Birmingham, Birmingham, AL., Menon M; Fred Hutchinson Cancer Center and University of Washington, Seattle, WA., Odeny TA; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Sharon E; Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Dana-Farber Cancer Institute, Boston, MA., Wagner MJ; Fred Hutchinson Cancer Center and University of Washington, Seattle, WA.; Dana-Farber Cancer Institute, Boston, MA., Wang CJ; University of California San Francisco, San Francisco, CA., Bhardwaj N; Icahn School of Medicine at Mount Sinai Hospital, New York, NY., Friedlander PA; Icahn School of Medicine at Mount Sinai Hospital, New York, NY., Abdul-Hay M; Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY., Cornejo Castro EM; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Labo N; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Marshall VA; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Miley W; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Moore K; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Roshan R; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Whitby D; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Kask AS; Fred Hutchinson Cancer Center and University of Washington, Seattle, WA., Kaiser J; Fred Hutchinson Cancer Center and University of Washington, Seattle, WA., Han E; Cytel (Shanghai) Co Ltd, Shanghai, China., Wright A; Fred Hutchinson Cancer Center and University of Washington, Seattle, WA., Yarchoan R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Fling SP; Fred Hutchinson Cancer Center and University of Washington, Seattle, WA., Uldrick TS; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Fred Hutchinson Cancer Center and University of Washington, Seattle, WA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 02, pp. JCO2400640. Date of Electronic Publication: 2024 Oct 02.
Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration.
Autor:
Lurain K; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Polizzotto MN; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Krug LT; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Shoemaker G; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Singh A; HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, USA., Jensen SMR; HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, USA., Wyvill KM; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Ramaswami R; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Uldrick TS; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Yarchoan R; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Sereti I; HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, USA.
Publikováno v:
AIDS (London, England) [AIDS] 2023 Sep 01; Vol. 37 (11), pp. 1693-1703. Date of Electronic Publication: 2023 Jun 19.
Autor:
Marshall VA; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Cornejo Castro EM; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Goodman CA; Retroviral Evolution Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Labo N; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Liu I; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Fisher NC; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Moore KN; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Nair A; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Immonen T; Retroviral Evolution Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Keele BF; Retroviral Evolution Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Polizzotto MN; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Uldrick TS; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Mu Y; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Saswat T; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Krug LT; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., McBride KM; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Lurain K; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Ramaswami R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Yarchoan R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Whitby D; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2024 Jul 15; Vol. 20 (7), pp. e1012338. Date of Electronic Publication: 2024 Jul 15 (Print Publication: 2024).
Autor:
Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Uldrick TS; Fred Hutchinson Cancer Center, Seattle.
Publikováno v:
NEJM evidence [NEJM Evid] 2024 Apr; Vol. 3 (4), pp. EVIDe2400011. Date of Electronic Publication: 2024 Mar 26.
Autor:
Anidi IU; Critical Care Medicine and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Sakai S; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Brooks K; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Fling SP; Cancer Immunotherapy Trials Network, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Wagner MJ; Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Lurain K; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lindestam Arlehamn CS; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, California, USA., Knox KS; Department of Internal Medicine, College of Medicine Phoenix, University of Arizona Health Sciences, Phoenix, Arizona, USA., Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Uldrick TS; Cancer Immunotherapy Trials Network, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Sharon E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA., Barber DL; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Mar 31; Vol. 11 (5), pp. ofae183. Date of Electronic Publication: 2024 Mar 31 (Print Publication: 2024).
Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseases.
Autor:
Hansen ME; HIV/AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute., Mangusan R; HIV/AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute., Lurain K; HIV/AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute., Odeny T; HIV/AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute., George J; HIV/AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute., Lu C; Pharmacy Department, Clinical Center, National Institutes of Health., Manion M; HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases., Widell A; HIV/AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute., Ekwede I; HIV/AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute., Whitby D; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory., Gulley JL; Center for Immuno-oncology, Center for Cancer Research, National Cancer Institute., Kadri SS; Critical Care Medicine Department, Clinical Center., Elinoff JM; Critical Care Medicine Department, Clinical Center., Barochia A; Pulmonary Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Torabi-Parizi P; Critical Care Medicine Department, Clinical Center., Uldrick TS; HIV/AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute., Yarchoan R; HIV/AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute., Ramaswami R; HIV/AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute.
Publikováno v:
AIDS (London, England) [AIDS] 2022 Nov 15; Vol. 36 (14), pp. 1969-1978. Date of Electronic Publication: 2022 Jul 16.
Autor:
Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Uldrick TS; Oncology, Fred Hutchinson Cancer Center, Seattle, WA.
Publikováno v:
Blood advances [Blood Adv] 2023 Sep 26; Vol. 7 (18), pp. 5661-5662.
Autor:
Ramaswami R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Tagawa T; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Mahesh G; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Serquina A; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Koparde V; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Lurain K; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Dremel S; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Li X; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Mungale A; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Beran A; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Ohler ZW; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Bassel L; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Warner A; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Mangusan R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Widell A; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Ekwede I; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Krug LT; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Uldrick TS; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Yarchoan R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Ziegelbauer JM; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA. ziegelbauerjm@nih.gov.
Publikováno v:
Journal of translational medicine [J Transl Med] 2023 Sep 22; Vol. 21 (1), pp. 653. Date of Electronic Publication: 2023 Sep 22.
Autor:
Lurain K; HIV and AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI, Bethesda, MD. kathryn.lurain@nih.gov., Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI, Bethesda, MD., Marshall V; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD., Castro EMC; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD., Labo N; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD., Miley W; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD., Moore K; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD., Roshan R; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD., Mangusan R; HIV and AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI, Bethesda, MD., Jaffe ES; Laboratory of Pathology, CCR, NCI, Bethesda, MD., Pittaluga S; Laboratory of Pathology, CCR, NCI, Bethesda, MD., Wang HW; Laboratory of Pathology, CCR, NCI, Bethesda, MD., Roth M; Laboratory of Pathology, CCR, NCI, Bethesda, MD., Filie AC; Laboratory of Pathology, CCR, NCI, Bethesda, MD., Uldrick TS; HIV and AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI, Bethesda, MD., Whitby D; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD., Yarchoan R; HIV and AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI, Bethesda, MD.
Publikováno v:
Haematologica [Haematologica] 2023 Jul 01; Vol. 108 (7), pp. 1940-1944. Date of Electronic Publication: 2023 Jul 01.